[go: up one dir, main page]

AU2001269146A1 - Cationic amphipathic peptides and the application thereof in gene transfer vectors - Google Patents

Cationic amphipathic peptides and the application thereof in gene transfer vectors

Info

Publication number
AU2001269146A1
AU2001269146A1 AU2001269146A AU6914601A AU2001269146A1 AU 2001269146 A1 AU2001269146 A1 AU 2001269146A1 AU 2001269146 A AU2001269146 A AU 2001269146A AU 6914601 A AU6914601 A AU 6914601A AU 2001269146 A1 AU2001269146 A1 AU 2001269146A1
Authority
AU
Australia
Prior art keywords
application
gene transfer
transfer vectors
amphipathic peptides
cationic amphipathic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269146A
Inventor
Antonio Bernad Miana
Jesus Fominaya Gutierrez
Maria Angustias Gasset Vega
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDPLANT GENETICS SL
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Medplant Genetics S L
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medplant Genetics S L, Consejo Superior de Investigaciones Cientificas CSIC filed Critical Medplant Genetics S L
Publication of AU2001269146A1 publication Critical patent/AU2001269146A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001269146A 2000-07-20 2001-07-06 Cationic amphipathic peptides and the application thereof in gene transfer vectors Abandoned AU2001269146A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200001806 2000-07-20
ES200001806A ES2187320B1 (en) 2000-07-20 2000-07-20 AMPHIPATIC CATIONIC PEPTIDE AND ITS APPLICATION IN VECTOR OF GENE TRANSFER.
PCT/ES2001/000274 WO2002010197A1 (en) 2000-07-20 2001-07-06 Cationic amphipathic peptides and the application thereof in gene transfer vectors

Publications (1)

Publication Number Publication Date
AU2001269146A1 true AU2001269146A1 (en) 2002-02-13

Family

ID=8494340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269146A Abandoned AU2001269146A1 (en) 2000-07-20 2001-07-06 Cationic amphipathic peptides and the application thereof in gene transfer vectors

Country Status (3)

Country Link
AU (1) AU2001269146A1 (en)
ES (1) ES2187320B1 (en)
WO (1) WO2002010197A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2928909B1 (en) * 2012-12-07 2018-08-01 The Queen's University Of Belfast An amphipathic peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9714150D0 (en) * 1997-07-05 1997-09-10 Secr Defence Process for the preparation of lead zirconate titanate compounds
WO1999013719A1 (en) * 1997-09-18 1999-03-25 Gene Therapy Systems, Inc. Chemical modification of dna using peptide nucleic acid conjugates

Also Published As

Publication number Publication date
WO2002010197A1 (en) 2002-02-07
ES2187320B1 (en) 2004-09-16
ES2187320A1 (en) 2003-06-01

Similar Documents

Publication Publication Date Title
HUP0004639A3 (en) Chlamydia protein, gene sequence and uses thereof
GB9721909D0 (en) Gene delivery vectors and their uses
AU2001269709A1 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
AU2001257532A1 (en) Adenoviral vectors for tumor specific gene expression and uses thereof
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU5617200A (en) Nodavirus-based dna expression vector and uses thereof
AU2001269146A1 (en) Cationic amphipathic peptides and the application thereof in gene transfer vectors
AU1894601A (en) Novel gene and use thereof
AU6909700A (en) Gene transfer imaging and uses thereof
GB0020952D0 (en) Genes and proteins and their uses
AU2002213398A1 (en) Expression vectors and uses thereof
AU2001256319A1 (en) Histone h2a-derived peptides useful in gene delivery
AU2001234150A1 (en) Novel protein and gene encoding the same
AU7304000A (en) Virulence gene and protein, and their use
GB9930464D0 (en) Virullence gene and protein and their use
AU5217100A (en) Adenoviral vectors encoding interferon and their use in gene therapy
GB9930462D0 (en) Virulence gene and protein and their use
GB9930463D0 (en) Virulence gene and protein and their use
GB9908323D0 (en) Virulence gene and protein and their use
AU2002319200A1 (en) Vector and the use thereof in gene therapy methods
GB0003729D0 (en) Virulene gene and protein, and their use
AU4803200A (en) Pituitrone gene and polypeptides
AU2002304016A1 (en) Outer surface proteins, their genes, and their use
AU2001284655A1 (en) Nucleic acids, vectors, host cells, polypeptides and uses thereof